Anavex Life Sciences Corp (AVXL)

[Talon38]

Plex, I'm always the optimist and hope for the best on behalf of our little Rett girls and those suffering from AD, PD, and MS. My predictions:

- Start of RS trial - above $5 - with positive results $10 to $15

- Start of Alzheimer's P3 with the above - $20+ -as part of the ACTC trials. $25, good mid phase results, up to $50

- with all of the above and partnership with Biogen on M/S research 1/4 share swap or $75 ( Remember Biogen in 2013 paid Elan $3.25B plus significant percentage of sales for the remaining 50% of M/S drug, Tysabri)

- all of this positive and a bidding war breaks out with repatriated overseas cash for M&A. "Katie bar the Door", Triple digits!

All of this is very optimistic but will mean that human suffering will be eased soon than later!

The very best to all in 2018.....Be There.